Riskpilot← Back to searchSign inGet full accessIBD-enheten AB
ABIn liquidationOrg 5566730171Medical specialists activities · NACE 8622Est. 20040 employees
Revenue 2024
SEK 0
EBITDA margin
—
-52% vs 2024
Equity ratio
97.3%
Financial strength
Net profit 2024
SEK 26K
-51% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK 10K | -52% |
| Net profit | SEK 26K | -51% |
| Total assets | SEK 368K | -95% |
| Equity | SEK 358K | -95% |
| Employees | 0 | — |
Legal name
IBD-enheten AB
Org number
5566730171
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 december 2004
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Konsultation inom hälso- och sjukvård
Address
Phone
+4687551133
Email
avveckling@servando.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Revenue | 474 | 0 | 0 | 0 | 0 |
| Staff expenses | — | −56 | 50 | — | — |
| EBITDA | −185 | −30 | 64 | 21 | 10 |
| Depreciation & amort. | −123 | −10 | — | −0 | −0 |
| EBIT | −308 | −40 | 64 | 21 | 10 |
| Net financials | 36 | −0 | −12 | 32 | 16 |
| Profit before tax | −272 | −40 | 52 | 53 | 26 |
| Tax | −0 | −0 | — | −0 | −0 |
| Net profit | −272 | −41 | 52 | 53 | 26 |
| Item | 2021 | 2022 | 2023 | 2024 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 837 | 8 301 | 8 180 | 7 843 | 368 |
| Equity | 8 475 | 8 117 | 8 169 | 7 832 | 358 |
| Long-term debt | 0 | — | — | 0 | 0 |
| Short-term debt | 362 | 184 | 11 | 11 | 10 |
| Total debt | 362 | 184 | 11 | 11 | 10 |
EBITDA margin
1000000.0%
This company
15.8%
Market median
+6329014% vs market
20212024
Equity ratio
97.3%
This company
38.2%
Market median
+155% vs market
20212024
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20212024
Net profit margin
2600000.0%
This company
8.1%
Market median
+32098665% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-05-01 – 2024-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JF Liquidator | Liquidator | 2025 |
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
| Board of Directors | 2025 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
| Deputy Board Member | 2025 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IBD-enheten AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Fredrik Ståhl | Liquidator | 0 companies |
| Ann Madeleine Sundin | Board of Directors | 0 companies |
| Céline Elisabeth Löfberg Fauvelle | Deputy Board Member | 0 companies |
| Birgitta Elisabeth Löfberg Fauvelle | Board of Directors | 0 companies |
| Robert Löfberg | Chairman | 0 companies |
| Maria Elisabeth Edward | Deputy Board Member | 0 companies |